Clinical trials historically struggled with several key inefficiencies, many of which became painfully apparent during the COVID-19 pandemic, such as the traditional paper-based, manual rev
Supply chain disruptions are taking centre stage in the media landscape at the outset of 2024, with incidents ranging from blockages in the Panama and Suez Canals to escalating geopolitical
On International Women’s Day, pharmaphorum looks back to an interview with data infrastructure and analytics company Kalderos’ CEO Angie Franks, a longtime healthcare executive, speaking wi
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
